Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 2
2008 3
2009 2
2010 2
2011 3
2012 2
2013 4
2014 3
2015 3
2016 3
2017 2
2018 7
2019 7
2020 3
2021 7
2022 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease.
Chertow GM, Vart P, Jongs N, Toto RD, Gorriz JL, Hou FF, McMurray JJV, Correa-Rotter R, Rossing P, Sjöström CD, Stefánsson BV, Langkilde AM, Wheeler DC, Heerspink HJL; DAPA-CKD Trial Committees and Investigators. Chertow GM, et al. J Am Soc Nephrol. 2021 Sep;32(9):2352-2361. doi: 10.1681/ASN.2021020167. Epub 2021 Jul 16. J Am Soc Nephrol. 2021. PMID: 34272327 Free PMC article. Clinical Trial.
BACKGROUND: In the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized, placebo-controlled trial, the sodium-glucose cotransporter 2 inhibitor dapagliflozin significantly reduced risk of kidney failure and prolonged survi …
BACKGROUND: In the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized, placebo-controll …
Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease.
Agarwal R, Sinha AD, Cramer AE, Balmes-Fenwick M, Dickinson JH, Ouyang F, Tu W. Agarwal R, et al. N Engl J Med. 2021 Dec 30;385(27):2507-2519. doi: 10.1056/NEJMoa2110730. Epub 2021 Nov 5. N Engl J Med. 2021. PMID: 34739197 Free PMC article. Clinical Trial.
BACKGROUND: Little evidence has been available to support the use of thiazide diuretics to treat hypertension in patients with advanced chronic kidney disease. METHODS: We randomly assigned patients with stage 4 chronic kidney disease and …
BACKGROUND: Little evidence has been available to support the use of thiazide diuretics to treat hypertension in patients with advanced chro …
The kidney and bisphosphonates.
Miller PD. Miller PD. Bone. 2011 Jul;49(1):77-81. doi: 10.1016/j.bone.2010.12.024. Epub 2011 Jan 11. Bone. 2011. PMID: 21232648 Review.
Nevertheless in the doses that are registered for the management of postmenopausal osteoporosis (PMO), oral bisphosphonates have never been shown to adversely affect the kidney, even (in post-hoc analysis of clinical trial data) down to estimated glomerular filtrati …
Nevertheless in the doses that are registered for the management of postmenopausal osteoporosis (PMO), oral bisphosphonates have never been …
Chronic Kidney Disease and Related Long-Term Complications After Liver Transplantation.
Sharma P, Bari K. Sharma P, et al. Adv Chronic Kidney Dis. 2015 Sep;22(5):404-11. doi: 10.1053/j.ackd.2015.06.001. Adv Chronic Kidney Dis. 2015. PMID: 26311603 Free PMC article. Review.
Since the adoption of model for end-stage liver disease (MELD)-based allocation policy, the incidence of post-transplant end stage renal disease has risen significantly. Occurrence of Stage 4 chronic kidney disease and end stage renal disease su …
Since the adoption of model for end-stage liver disease (MELD)-based allocation policy, the incidence of post-transplant end stage renal dis …
Insulinoma mimic: methadone-induced hypoglycaemia.
Kanbour S, Balaji A, Chae K, Mathioudakis N. Kanbour S, et al. BMJ Case Rep. 2022 Jul 26;15(7):e245890. doi: 10.1136/bcr-2021-245890. BMJ Case Rep. 2022. PMID: 35882435 Free PMC article.
Here, we describe a woman in her 70s with history of opioid use disorder on methadone, stage 4 chronic kidney disease and prior hypoglycaemic episodes who initially presented with perforated gastric ulcer requiring surgical repair. ...
Here, we describe a woman in her 70s with history of opioid use disorder on methadone, stage 4 chronic kidney …
Risk Assessment of Chronic Kidney Disease following Microwave Ablation for Stage T1 Renal Cell Carcinoma.
Zhou W, Herwald SE, Uppot RN, Arellano RS. Zhou W, et al. J Vasc Interv Radiol. 2018 Dec;29(12):1685-1691. doi: 10.1016/j.jvir.2018.06.021. Epub 2018 Oct 5. J Vasc Interv Radiol. 2018. PMID: 30297311

The 2-years freedom from eGFR decrease to < 60 mL/min/1.73 m(2) was 2% (P = .91). Among the 5 patients (13%) with preexisting stage 4 chronic kidney disease (CKD; eGFR < 30 mL/min/1.73 m(2)) before ablation, there was no significant postab

…

The 2-years freedom from eGFR decrease to < 60 mL/min/1.73 m(2) was 2% (P = .91). Among the 5 patients (13%) with preexisting stage

…
Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.
de Zeeuw D, Akizawa T, Audhya P, Bakris GL, Chin M, Christ-Schmidt H, Goldsberry A, Houser M, Krauth M, Lambers Heerspink HJ, McMurray JJ, Meyer CJ, Parving HH, Remuzzi G, Toto RD, Vaziri ND, Wanner C, Wittes J, Wrolstad D, Chertow GM; BEACON Trial Investigators. de Zeeuw D, et al. N Engl J Med. 2013 Dec 26;369(26):2492-503. doi: 10.1056/NEJMoa1306033. Epub 2013 Nov 9. N Engl J Med. 2013. PMID: 24206459 Free PMC article. Clinical Trial.
Whether nuclear 1 factor (erythroid-derived 2)-related factor 2 activators further reduce this risk is unknown. METHODS: We randomly assigned 2185 patients with type 2 diabetes mellitus and stage 4 chronic kidney disease (estimated glomer …
Whether nuclear 1 factor (erythroid-derived 2)-related factor 2 activators further reduce this risk is unknown. METHODS: We randomly …
Thromboembolism and bleeding in patients with atrial fibrillation and stage 4 chronic kidney disease: impact of biomarkers.
Matusik PT, Leśniak WJ, Heleniak Z, Undas A. Matusik PT, et al. Kardiol Pol. 2021;79(10):1086-1092. doi: 10.33963/KP.a2021.0088. Epub 2021 Aug 15. Kardiol Pol. 2021. PMID: 34392517 Free article.
BACKGROUND: Chronic kidney disease (CKD) is considered a risk factor for thromboembolic and bleeding events in patients with atrial fibrillation (AF). AIMS: We sought to assess predictors of clinical outcomes among AF patients with advanced CKD. METHODS: In a prospective c …
BACKGROUND: Chronic kidney disease (CKD) is considered a risk factor for thromboembolic and bleeding events in patients with atrial fibrilla …
Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study.
Robinson DE, Ali MS, Strauss VY, Elhussein L, Abrahamsen B, Arden NK, Ben-Shlomo Y, Caskey F, Cooper C, Dedman D, Delmestri A, Judge A, Javaid MK, Prieto-Alhambra D. Robinson DE, et al. Health Technol Assess. 2021 Mar;25(17):1-106. doi: 10.3310/hta25170. Health Technol Assess. 2021. PMID: 33739919 Free PMC article.
BACKGROUND: Bisphosphonates are contraindicated in patients with stage 4+ chronic kidney disease. However, they are widely used to prevent fragility fractures in stage 3 chronic kidney disease, despite a lack of good-quality data on their effect …
BACKGROUND: Bisphosphonates are contraindicated in patients with stage 4+ chronic kidney disease. However …
Clinical and economic outcomes in Medicare beneficiaries with stage 3 or stage 4 chronic kidney disease and anemia: the role of intravenous iron therapy.
Knight TG, Ryan K, Schaefer CP, D'Sylva L, Durden ED. Knight TG, et al. J Manag Care Pharm. 2010 Oct;16(8):605-15. doi: 10.18553/jmcp.2010.16.8.605. J Manag Care Pharm. 2010. PMID: 20866165 Free PMC article.
OBJECTIVE: To examine the use of intravenous (IV) iron and its associated economic and clinical outcomes in Medicare beneficiaries with stage 3 or stage 4 CKD and anemia. ...Therapy with oral iron was not measurable with this database. Clinical and economic outcomes …
OBJECTIVE: To examine the use of intravenous (IV) iron and its associated economic and clinical outcomes in Medicare beneficiaries wi …
55 results